SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001636050-21-000033
Filing Date
2021-03-24
Accepted
2021-03-24 19:21:43
Documents
1
Period of Report
2021-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161662808813010.html 4  
1 FORM 4 wf-form4_161662808813010.xml 4 3629
  Complete submission text file 0001636050-21-000033.txt   5304
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 11 TIMES SQUARE, 33RD FLOOR NEW YORK NY 10036
Business Address
Cheruvu Pavan (Reporting) CIK: 0001731741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 21769594